You just read:

Invaron Pharmaceuticals and the Center for Assisted Reproduction (CARE) Initiate Investigator Led Phase III Clinical Study on INVOcell(TM)

News provided by

Invaron Pharmaceuticals Inc.

Feb 28, 2013, 04:28 EST